Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-1-27
pubmed:abstractText
This study was designed to characterize ocular penetration pathways of ESBA105, a topically administered single-chain antibody (scFv) against tumor necrosis factor (TNF)-alpha, to the anterior and posterior segment of the eye.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1552-5783
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
779-86
pubmed:meshHeading
pubmed-meshheading:18757511-Absorption, pubmed-meshheading:18757511-Administration, Topical, pubmed-meshheading:18757511-Animals, pubmed-meshheading:18757511-Anterior Eye Segment, pubmed-meshheading:18757511-Antibodies, Monoclonal, pubmed-meshheading:18757511-Aqueous Humor, pubmed-meshheading:18757511-Biological Availability, pubmed-meshheading:18757511-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:18757511-Half-Life, pubmed-meshheading:18757511-Immunoglobulin Fragments, pubmed-meshheading:18757511-Immunoglobulin Variable Region, pubmed-meshheading:18757511-Male, pubmed-meshheading:18757511-Ophthalmic Solutions, pubmed-meshheading:18757511-Rabbits, pubmed-meshheading:18757511-Retina, pubmed-meshheading:18757511-Tissue Distribution, pubmed-meshheading:18757511-Tumor Necrosis Factor-alpha, pubmed-meshheading:18757511-Vitreous Body
pubmed:year
2009
pubmed:articleTitle
Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
pubmed:affiliation
ESBATech AG, Schlieren, Switzerland.
pubmed:publicationType
Journal Article